Complix
0 followers
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.
Org chart
Mark Vaeck
CEO
Board & advisors
Hans Schikan
Non-Executive Director & Chairman
Gaston Matthyssens
Non-Executive Director
Johan Cardoen
Non-Executive Director
Tom Aerts
Non-Executive Director